
    
      Evaluation Design: This is a multi-center post market observational survey designed to
      collect procedural data on a minimum of 50 HeRO™ patients in the commercialization phase.
      Data will be collected retrospectively for patients already implanted with the HeRO™ device
      in the commercialization phase or prospectively for patients that receive the HeRO™ Device
      during the data collection period. No special patient screening, testing, or procedures are
      required. There is no required patient follow-up.

      Subject Population: Any patients the investigator deems/deemed eligible for HeRO™ implant
      with complete procedural data are eligible for inclusion in this post market observational
      survey.

      Endpoints: None

      Inclusion/Exclusion Criteria: There are no formal screening criteria other than patients must
      have all required procedural data points available for recording on the case report form.
    
  